The ratio of complete hydatidiform mole and partial hydatidiform mole by using p57 immunohistochemical stain

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20200923002

Enrollment

Registered

2020-09-23

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complete hydatidiform mole Partial hydatidiform mole Hydatidiform mole Molar pregnancy Hydropic abortus Complete hydatidiform mole Partial hydatidiform mole Hydatidiform mole Molar pregnancy Hydropic abortus

Interventions

Specimens were diagnosed as complete hydatidiform mole by using routine staining and p57 immunohistochemistry

Diagnostic

Complete hydatidiform mole

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients who had a pathological diagnosis of hydatidiform mole or hydropic chrorionic villi from intrauterine content.

Exclusion criteria

Exclusion criteria: Patients who had treat by chemotherapy. Loss of paraffin blocks.

Design outcomes

Primary

Measure	Time frame
The ratio between complete hydatidiform mole and partial hydatidiform mole at the beginning of study glass slides with p57 immunostaining	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactMonsiri Jinapen

Department of Pathology, Faculty of Medicine, Khon Kaen University

monsiriforce@gmail.com0830945349

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026